Zou Y L, Zhang J D, Chen M H, Shi G Q, Prignot J, Cocito C
Microbiology and Genetics Unit, University of Louvain, Brussels, Belgium.
Clin Infect Dis. 1994 Dec;19(6):1084-91. doi: 10.1093/clinids/19.6.1084.
IgA, IgG, and IgM antibodies to mycobacterial antigen A60 were measured by ELISA in blood, pleural fluid, and cerebrospinal fluid from 560 patients with pulmonary and/or extrapulmonary tuberculosis who were being treated at hospitals in northern China and from 734 uninfected controls. Among 529 healthy persons (most of whom had been vaccinated with bacille Calmette-Guérin [BCG] and 287 of whom were tuberculin-positive), the rate of false-positive results was negligible; this observation ruled out interference of remote BCG vaccination with A60 assays at the chosen cutoff level. Rates of positivity for IgM and IgG, respectively, were 80% and 36% among patients with active primary pulmonary tuberculosis, 31% and 88.5% among patients with active postprimary pulmonary tuberculosis, 0 and 41% among patients with inactive pulmonary tuberculosis, and 30%-61% and 69%-86% among patients with extrapulmonary tuberculosis. Paired samples of blood and pleural fluid from patients with pleurisy contained IgA antibody to A60 at equal titers; in contrast, most patients with tuberculous meningitis (100% of whom had a positive ELISA result) had higher levels of IgG antibody to A60 in cerebrospinal fluid than in blood--proof of intrathecal synthesis.
采用酶联免疫吸附测定(ELISA)法检测了来自中国北方医院正在接受治疗的560例肺结核和/或肺外结核患者以及734例未感染对照者的血液、胸水和脑脊液中抗分枝杆菌抗原A60的IgA、IgG和IgM抗体。在529名健康人(其中大多数接种过卡介苗[BCG],287人结核菌素呈阳性)中,假阳性结果的发生率可忽略不计;这一观察结果排除了在选定的临界值水平下既往BCG接种对A60检测的干扰。活动性原发性肺结核患者中IgM和IgG的阳性率分别为80%和36%,活动性继发性肺结核患者中分别为31%和88.5%,非活动性肺结核患者中分别为0和41%,肺外结核患者中分别为30%-61%和69%-86%。胸膜炎患者的配对血液和胸水样本中抗A60的IgA抗体效价相等;相比之下,大多数结核性脑膜炎患者(100% ELISA结果呈阳性)脑脊液中抗A60的IgG抗体水平高于血液——这是鞘内合成的证据。